Results 31 to 40 of about 653,483 (216)

Animal model evaluation of a novel renal denervation system for future laparoscopic treatment of resistant hypertension [PDF]

open access: yesInvestigative and Clinical Urology, 2020
Purpose: Although percutaneous catheter-based ablation of renal sympathetic nerve fibers has been used in the treatment of patients with resistant hypertension, a recent phase III study did not confirm its efficacy.
Won Hoon Song   +5 more
doaj   +1 more source

Renal denervation for the management of hypertension. Joint position statement from the SEH-LELHA and the ACI-SEC

open access: yesREC: Interventional Cardiology (English Ed.), 2022
Hypertension is the most prevalent cardiovascular risk factor. Despite pharmacological treatment, a high percentage of patients do not achieve an adequate blood pressure control.
Oriol Rodríguez-Leor   +13 more
doaj   +1 more source

Eligibility for renal denervation: experience at 11 European expert centers [PDF]

open access: yes, 2014
Based on the SYMPLICITY studies and CE (Conformité Européenne) certification, renal denervation is currently applied as a novel treatment of resistant hypertension in Europe.
Jin, Yu   +82 more
core   +1 more source

The promise of renal denervation

open access: yesCleveland Clinic Journal of Medicine, 2012
Only with further carefully conducted randomized trials of renal denervation will its full promise be realized.
Deepak L, Bhatt, George L, Bakris
openaire   +2 more sources

Renal Denervation for Hypertension

open access: yesJACC: Cardiovascular Interventions, 2012
Systemic hypertension is a major burden to the individual and society. Its association with major adverse cardiac and cerebral events and favorable effects of antihypertensive therapy are undisputed. However, despite multidrug therapy, blood pressures are frequently suboptimally controlled.
Bertog, Stefan C.   +2 more
openaire   +2 more sources

Renal denervation for resistant hypertension: no

open access: yesInternal and Emergency Medicine, 2016
In recent years, catheter-based radiofrequency denervation of the renal arteries (RDN) has emerged as a potential treatment for resistant hypertension. Though initial non-randomized and randomized small studies demonstrate large reductions in office blood pressure, RDN superiority to conventional treatment is not confirmed either by randomized ...
TADDEI, STEFANO   +2 more
openaire   +3 more sources

First-in-Man Robotic-Assisted Renal Denervation

open access: yes, 2022
To the best of our knowledge, this is the first report of robotic-assisted renal denervation. Robotic-assisted renal denervation represents a new frontier in robotic-assisted percutaneous interventions.
Ohashi, Hirofumi   +9 more
core   +1 more source

Hyperresponders vs. nonresponder patients after renal denervation

open access: yes, 2014
BACKGROUND: Blood pressure (BP) response after renal denervation (RDN) is highly variable. Besides baseline BP, no reliable predictors of response have been consistently identified.
Persu, A.   +61 more
core   +1 more source

Successful accessory renal artery denervation in a patient with resistant hypertension

open access: yesHeart Views, 2014
Renal sympathetic denervation is safe and effective in patients with resistant hypertension. In all of the studies of renal artery denervation, patients with accessory renal arteries are excluded.
Halil Atas   +3 more
doaj   +1 more source

Device-Based Treatment in Hypertension: At the Forefront of Renal Denervation

open access: yesCardiology Discovery, 2021
. Percutaneous renal denervation is a novel device therapy that modifies the circulatory regulatory system and has received considerable attention recently.
Kazuomi Kario   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy